RxDoctor Payments Data

Nitipong Permpalung, MD

Infectious Disease · Baltimore, MDNPI 1134483423

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $800 of the $800 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Shionogi Inc.

$800in general payments, 2019–2025

Across 1 payment — averaging $800.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shionogi Inc$800
$198,752in research payments, 2019–2025

Across 3 payments — averaging $66,251 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$174K
  • Scynexis, Inc.$25K

What the payments were for

  • Consulting fees$800100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Shionogi Inc1$800

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$800 in reported general payments places this provider in the 60th percentile of 289 infectious disease providers in Maryland.

See all infectious disease providers in Maryland

Medicare billing

Part B allowed, 2024
$50,501
Medicare patients
168
Services billed
323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →